The Biology of GHDD: Why Blood and Bone are Linked

Understanding the biology of Ghosal hematodiaphyseal dysplasia (GHDD) helps explain why a single genetic change can affect both energy levels and bone structure. This condition is driven by a disruption in how the body handles inflammation and bone remodeling.

The Role of the TBXAS1 Gene

At the center of GHDD is a gene called TBXAS1. This gene provides the instructions for an enzyme that acts like a traffic controller for certain fats in the body ^[1].

In a healthy body, this enzyme converts a substance called prostaglandin H2 (PGH2) into thromboxane A2, which helps with normal blood clotting and vessel health ^[1][2]. When the TBXAS1 gene has a pathogenic variant on both copies (one from each parent), this traffic controller stops working. The proposed disease model is that because the PGH2 cannot be converted into thromboxane, it “backs up” and is forced into other pathways ^[1].

This excess PGH2 is converted into other substances, such as prostaglandin E2 (PGE2) and other inflammatory mediators ^[1]. This creates a state of chronic, low-level inflammation. This proposed inflammatory signaling may be responsible for the two main features of GHDD:

• In the Marrow: It is thought to cause fibrosis (scarring) that replaces the healthy, blood-producing tissue, leading to anemia ^[3][4].
• In the Bones: It may signal the bone-building cells to work too hard, leading to the thickening of the long bones ^[5][6].

How GHDD is Diagnosed

Because GHDD is so rare, doctors use a combination of three main tools to confirm the diagnosis and rule out other conditions.

1. Blood Counts and Iron Studies

A complete blood count (CBC) measures the cells in the blood. In GHDD, anemia is common. While it is sometimes described as normocytic anemia (normal-sized red blood cells), the cell size can vary, so doctors must also check iron studies (like ferritin) and the reticulocyte response ^[1][7]. In some cases, the count of platelets (clotting cells) or white blood cells may also be low ^[7].

2. Bone Radiographs (X-rays)

Doctors look for specific patterns on plain X-rays of the long bones, like those in the arms and legs. Key findings include:

• Diaphyseal Sclerosis: An increased density or “whiteness” of the bone shafts ^[7].
• Cortical Thickening: The outer layer of the bone becomes unusually thick ^[5].
• Medullary Narrowing: The inner canal where the marrow lives becomes squeezed and narrow because the surrounding bone is so thick ^[5][8].

3. Genetic Testing

Confirmation of GHDD relies on genetic sequencing identifying biallelic variants in the TBXAS1 gene—meaning there is a change in both the copy inherited from the mother and the copy from the father ^[7][1]. Note that a variant of “uncertain significance” does not confirm the diagnosis; it must be interpreted by a specialist alongside clinical and molecular assessment, including parental testing.

Avoiding Misdiagnosis: The “Look-Alikes”

GHDD is often confused with two other rare conditions because they share some, but not all, of the same symptoms.

Camurati-Engelmann Disease (CED) is the most common look-alike because the X-rays can look almost identical to GHDD. However, patients with CED usually have normal blood counts and do not experience the marrow scarring or severe anemia seen in GHDD ^[8].

Iron-Refractory Iron Deficiency Anemia (IRIDA) causes a type of anemia that does not respond to iron supplements, similar to how the anemia in GHDD may seem. However, children with IRIDA have perfectly healthy bones with no changes on X-rays ^[9].

By using genetic testing and looking at both the blood and the bones, the medical team can ensure the correct diagnosis.